MainBoardListed
Mankind Pharma Limited

Mankind Pharma Limited

Company website
Investor note: Mankind Pharma Limited aims to raise ₹4,00,58,844 crore. The fresh issue of ₹0 crore goes to the company while the OFS of ₹0 crore is an existing-shareholder sale.
Subscription window: 25-04-2023 to 27-04-2023. Allotment and listing timelines: 04-05-2023 / 09-05-2023. Tip: check promoter holding and recent financials before applying.
Start Date25-04-2023
End Date27-04-2023
Listing Date09-05-2023
Allotment Date04-05-2023
Current Price₹1,300
GMP₹180 (16.67%)
Lot Size13 Shares
Subscription15.32 Times
Face Value₹1 Per Share
Listing atNSE, BSE
Issue Price₹1026 - ₹1080
Pre Issue₹40,05,88,440
Post Issue₹40,05,88,440
Issue Size₹4,00,58,844
(aggregating up to 4326.36 Cr)
Fresh Issue
(aggregating up to 0.00 Cr)
Offer For Sale
(aggregating up to 4326.36 Cr)
The Grey Market Premium (GMP) for Mankind Pharma Limited is currently around ₹180 (16.67%). This indicates an estimated listing price of approximately ₹1,206 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.

Gmp Details

Last UpdatedIPO PriceGMPEstimated Listing Price
11 Nov 2025, 11:52
₹1,080
₹180
₹1,260 (16.67%)
21 Mar 2025, 12:08
₹1,080
₹180
₹1,260 (16.67%)

Financials overview In Crores

Here is a quick look at the recent financial performance of Mankind Pharma Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.

Key Performance

KPIValues
33.20
33.20
ROE
27.60
ROCE
26.10
27.70
27.70
33.20
32.5
0
0

Subscription Demand (in ₹ Crore)

CategoryOfferedDemandTimes
QIBs
₹822.01
42534.08
51.74
RETAIL
₹1,438.51
1388.45
0.97
HNIs 2+
₹205.50
304.8
1.48
HNIs 10+
₹411
2160.05
5.26
Total
₹2,877.02
46387.38
16.12
The IPO reservation for Mankind Pharma Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.

IPO Reservation

CategoryShares OffersNo. of Shares
QIB
50.00%
2,00,29,421
NII (HNI)
15.00%
60,08,827
RETAIL
35.00%
1,40,20,596
TOTAL
100.00%
4,00,58,844

Lot(s) Distribution

CategoryLot(s)QtyAmountReserved
Retail (Min)
1
13
₹14,040
0
sHNI
15
195
₹2,10,600
0
bHNI
72
936
₹10,10,880
0
Below you can find the official contact details of Mankind Pharma Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.

Company Details

Phone: +91 11 4684 6700
Address: 208, Okhla Industrial Estate Phase-III, New Delhi 110020

IPO Registrar

Name: KFin Technologies Limited
Phone: 04067162222
Mankind Pharma Limited IPO Details — GMP: ₹180 (16.67%) | Grey Market IPO